YD Bio Revenue

In the year 2024, YD Bio had annual revenue of $510.36K with 45.76% growth. YD Bio had revenue of $142.69K in the quarter ending December 31, 2024, with 95.63% growth.

Revenue (ttm)

$510.36K

Revenue Growth

+45.76%

P/S Ratio

414.73

Revenue / Employee

n/a

Employees

n/a

Market Cap

211.66M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	510.36K	160.23K	45.76%
Dec 31, 2023	350.13K	-13.99K	-3.84%
Dec 31, 2022	364.12K	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

YDES News

5 weeks ago - YD Bio Limited Reports Full Year 2025 Financial Results - GlobeNewsWire
2 months ago - YD Bio and EG BioMed Jointly Launch Nationwide Telehealth Platform to Accelerate Commercialization of Cancer Detection and Decentralized Clinical Services Across the United States - GlobeNewsWire
2 months ago - YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem - GlobeNewsWire
3 months ago - YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform - GlobeNewsWire
4 months ago - YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy - GlobeNewsWire
5 months ago - YD Bio Enters into MOU to Merge with EG BioMed, Advancing DNA Methylation–Driven AI Platforms for Cancer Diagnostics and Drug Development - GlobeNewsWire
5 months ago - YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap - GlobeNewsWire
6 months ago - YD Bio Limited Expands U.S. Presence with Newly Planned California Facilities and Operations Center - GlobeNewsWire

More News